- Report
- January 2025
- 180 Pages
Global
From €2364EUR$2,490USD£1,994GBP
- Report
- July 2024
- 205 Pages
Global
From €2174EUR$2,290USD£1,834GBP
- Report
- February 2025
- 200 Pages
Global
From €4262EUR$4,490USD£3,595GBP
- Report
- January 2025
- 200 Pages
Global
From €4262EUR$4,490USD£3,595GBP
- Report
- September 2024
- 175 Pages
Global
From €4747EUR$5,000USD£4,004GBP
- Report
- July 2024
- 175 Pages
Global
From €4747EUR$5,000USD£4,004GBP
- Report
- March 2025
- 200 Pages
Global
From €4262EUR$4,490USD£3,595GBP
- Report
- February 2025
- 200 Pages
Global
From €4262EUR$4,490USD£3,595GBP
- Report
- February 2025
- 200 Pages
Global
From €4262EUR$4,490USD£3,595GBP
- Report
- December 2024
- 175 Pages
Global
From €4747EUR$5,000USD£4,004GBP
- Report
- October 2024
- 175 Pages
Global
From €4747EUR$5,000USD£4,004GBP
- Report
- September 2024
- 175 Pages
Global
From €4747EUR$5,000USD£4,004GBP
- Report
- May 2024
- 184 Pages
Global
From €4272EUR$4,500USD£3,603GBP
- Report
- May 2024
- 187 Pages
Global
From €4272EUR$4,500USD£3,603GBP
- Report
- July 2024
- 150 Pages
Global
From €3560EUR$3,750USD£3,003GBP
- Report
- July 2024
- 150 Pages
Global
From €3560EUR$3,750USD£3,003GBP
- Report
- July 2024
- 100 Pages
Global
From €3560EUR$3,750USD£3,003GBP
- Report
- July 2024
- 100 Pages
Global
From €3560EUR$3,750USD£3,003GBP
- Report
- April 2024
- 145 Pages
Global
From €3750EUR$3,950USD£3,163GBP
- Report
- August 2024
- 200 Pages
Global
From €3673EUR$3,869USD£3,098GBP

The Implantable Cardioverter Defibrillator (ICD) market is a segment of the Cardiovascular Devices market. ICDs are medical devices used to treat life-threatening arrhythmias, or abnormal heart rhythms. They are implanted in the chest and monitor the heart's electrical activity. When an abnormal rhythm is detected, the device delivers an electrical shock to restore normal rhythm. ICDs are used to treat ventricular tachycardia and ventricular fibrillation, two of the most common causes of sudden cardiac death.
The ICD market is driven by the increasing prevalence of cardiovascular diseases, technological advancements, and the growing demand for minimally invasive treatments. The market is expected to grow at a steady rate over the forecast period.
Some of the major players in the ICD market include Medtronic, Abbott, Boston Scientific, Biotronik, LivaNova, and Sorin Group. Show Less Read more